ODG
BIIB icon

O'Dell Group’s Biogen BIIB Stock Holding History

O'Dell Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-64
Closed -$16.6K – 134
2023
Q4 		$16.6K Buy
+64
New +$15.7K ﹤0.01% 311
2023
Q3 		– Sell
-64
Closed -$18.2K – 121
2023
Q2 		$18.2K Buy
+64
New +$19.1K 0.01% 287
2022
Q4 		– Sell
-64
Closed -$17K – 113
2022
Q3 		$17K Hold
64
– – 0.01% 241
2022
Q2 		$13K Sell
64
-117
-65% -$23.9K ﹤0.01% 260
2022
Q1 		$38K Hold
181
– – 0.01% 201
2021
Q4 		$43K Hold
181
– – 0.01% 180
2021
Q3 		$51K Buy
+181
New +$59.3K 0.02% 159

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

O'Dell Group's BIIB Position: Q1 2024 in Review

O'Dell Group sold out of Biogen (BIIB) in Q1 2024, closing a stake of 64 shares — an estimated $16.6K sold.

O'Dell Group first reported a position in BIIB in Q3 2021 and held it in 7 quarters. The position peaked at $51K in Q3 2021. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • O'Dell Group reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • O'Dell Group sold 64 Biogen shares in Q1 2024, an estimated $16.6K.
  • O'Dell Group first reported a position in Biogen in Q3 2021 and held it in 7 quarters.
  • O'Dell Group's Biogen position peaked at $51K in Q3 2021.
  • 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.